Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Pamela Wilkerson

Pamela Wilkerson

Juliana

Pamela P. Wilkerson, President of LMC Creative, Inc., has nearly three decades of experience as a marketing professional in the medical device and healthcare industries. Before embarking on her agency career in 2007, Ms. Wilkerson spent more than 13 years in the medical device sterilization business. As Director of Corporate Communications with Sterigenics International, she was instrumental in the company’s merger with IBA and was soon after appointed Vice President of Corporate Communications & Investor Relations. Her experience includes brand development, image building, strategic marketing, competitive analysis, customer relationship management, investor and public relations, fiscal planning, event planning, and media management. Ms. Wilkerson holds a degree in marketing and business management from Texas A&M University.

Share

Related Content

  • Practice Management

From feasibility to first patient: optimizing clinical trial success

  • Neurotrophic Keratitis

Autologous serum eye drops improve symptoms and corneal nerve parameters in neurotrophic keratitis

  • Ocular Surface Disease

Dry eye diagnostic practices remain inconsistent worldwide, survey finds

  • Myopia

Low-dose atropine slowed myopia progression in children with advanced myopia in pilot trial

  • Glaucoma

Global glaucoma disability rates decline despite rising case burden

  • Myopia

Red-light therapy outperforms low-dose atropine in altering macular morphology

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon